Barth Syndrome Heart Treatment Study
Part of Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This trial tests a medicine called elamipretide (4TAZ) in boys with Barth Syndrome, a genetic condition affecting the heart and muscles. The goal is to see if this medicine can help improve heart function and how the body uses energy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been genetically diagnosed with Barth Syndrome (a mutation in the TAZ gene)
- You are a male aged 5 years or older
- Your heart's pumping strength (ejection fraction) is at least 50%
- If you take heart medications, you've been on the same doses for at least 3 months
- You or a caregiver can give yourself or receive injections of the study medicine
- You have not been in another drug trial in the past 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new gene therapy called SGT-501 for people with a genetic heart condition called CPVT, which can cause dangerous fast heartbeats. The goal is to see if the treatment can reduce these episodes.
This study tests whether using two implanted devices (CardioMems and BaroStim) can improve heart function and symptoms in people with advanced heart failure. It aims to help patients who are already on standard medications get even better results.
This trial tests a new medicine, adimanebart, for people with certain types of congenital myasthenic syndrome (CMS), a condition that causes muscle weakness. The study aims to see if the medicine improves muscle strength and daily function, and it includes both teenagers and adults.
This trial tests a drug called sotatercept for people with Eisenmenger syndrome caused by certain unrepaired heart defects. It aims to see if the drug can improve exercise ability and overall well-being.
This trial tests a new drug called sotatercept for people with Eisenmenger syndrome or a related heart defect that hasn't been repaired. It may help if current treatments aren't working well enough.
This trial tests whether starting specific medicines for CTEPH and then doing balloon pulmonary angioplasty (BPA) can improve how well the right side of the heart is working. It may help people who cannot have surgery (PTE) and are newly starting CTEPH/PAH-targeted treatment.
Hear when a new Barth Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.